Lung-on-a-chip is a type of organ-on-a-chip (OoC) technology [8] that replicates the functions of the human lung on a microfluidic chip. The lung-on-a-chip consists of a transparent polymer membrane that is lined with living lung cells, including airway and blood vessel cells. The chip also includes microchannels that simulate the airflow and mechanical forces present in the lung.
The lung-on-a-chip technology aims to provide a more accurate and reliable platform for drug discovery, toxicity testing, and disease modeling for lung-related diseases such as asthma, chronic obstructive pulmonary disease (COPD), and lung cancer. Researchers can use lung-on-a-chip technology to study the effects of various environmental factors, pollutants, and drugs on lung function and disease development.
Moreover, lung-on-a-chip technology has the potential to revolutionize the field of regenerative medicine. By creating a platform that mimics the structure and function of the lung, researchers can study the behavior of stem cells and other cell types in a microenvironment that is similar to lung tissue, and develop new strategies for repairing damaged lung tissue or even creating new lung tissue for transplantation.
Report Highlights
Report Scope
This report aims to provide a comprehensive presentation of the global market for Lung-on-a-chip, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung-on-a-chip.
The Lung-on-a-chip market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Lung-on-a-chip market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lung-on-a-chip companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Segment by Type
Segment by Application
By Region
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lung-on-a-chip companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries. It introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung-on-a-chip Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Pulmonary Inflammation
1.2.3 Pulmonary Infection
1.3 Market by Application
1.3.1 Global Lung-on-a-chip Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Academic & Research Institutes
1.3.4 Other End Users
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lung-on-a-chip Market Perspective (2018-2029)
2.2 Lung-on-a-chip Growth Trends by Region
2.2.1 Global Lung-on-a-chip Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Lung-on-a-chip Historic Market Size by Region (2018-2023)
2.2.3 Lung-on-a-chip Forecasted Market Size by Region (2024-2029)
2.3 Lung-on-a-chip Market Dynamics
2.3.1 Lung-on-a-chip Industry Trends
2.3.2 Lung-on-a-chip Market Drivers
2.3.3 Lung-on-a-chip Market Challenges
2.3.4 Lung-on-a-chip Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lung-on-a-chip Players by Revenue
3.1.1 Global Top Lung-on-a-chip Players by Revenue (2018-2023)
3.1.2 Global Lung-on-a-chip Revenue Market Share by Players (2018-2023)
3.2 Global Lung-on-a-chip Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Lung-on-a-chip Revenue
3.4 Global Lung-on-a-chip Market Concentration Ratio
3.4.1 Global Lung-on-a-chip Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung-on-a-chip Revenue in 2022
3.5 Lung-on-a-chip Key Players Head office and Area Served
3.6 Key Players Lung-on-a-chip Product Solution and Service
3.7 Date of Enter into Lung-on-a-chip Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lung-on-a-chip Breakdown Data by Type
4.1 Global Lung-on-a-chip Historic Market Size by Type (2018-2023)
4.2 Global Lung-on-a-chip Forecasted Market Size by Type (2024-2029)
5 Lung-on-a-chip Breakdown Data by Application
5.1 Global Lung-on-a-chip Historic Market Size by Application (2018-2023)
5.2 Global Lung-on-a-chip Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Lung-on-a-chip Market Size (2018-2029)
6.2 North America Lung-on-a-chip Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Lung-on-a-chip Market Size by Country (2018-2023)
6.4 North America Lung-on-a-chip Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lung-on-a-chip Market Size (2018-2029)
7.2 Europe Lung-on-a-chip Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Lung-on-a-chip Market Size by Country (2018-2023)
7.4 Europe Lung-on-a-chip Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lung-on-a-chip Market Size (2018-2029)
8.2 Asia-Pacific Lung-on-a-chip Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Lung-on-a-chip Market Size by Region (2018-2023)
8.4 Asia-Pacific Lung-on-a-chip Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lung-on-a-chip Market Size (2018-2029)
9.2 Latin America Lung-on-a-chip Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Lung-on-a-chip Market Size by Country (2018-2023)
9.4 Latin America Lung-on-a-chip Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lung-on-a-chip Market Size (2018-2029)
10.2 Middle East & Africa Lung-on-a-chip Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Lung-on-a-chip Market Size by Country (2018-2023)
10.4 Middle East & Africa Lung-on-a-chip Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Emulate
11.1.1 Emulate Company Detail
11.1.2 Emulate Business Overview
11.1.3 Emulate Lung-on-a-chip Introduction
11.1.4 Emulate Revenue in Lung-on-a-chip Business (2018-2023)
11.1.5 Emulate Recent Development
11.2 Tissuse
11.2.1 Tissuse Company Detail
11.2.2 Tissuse Business Overview
11.2.3 Tissuse Lung-on-a-chip Introduction
11.2.4 Tissuse Revenue in Lung-on-a-chip Business (2018-2023)
11.2.5 Tissuse Recent Development
11.3 Hesperos
11.3.1 Hesperos Company Detail
11.3.2 Hesperos Business Overview
11.3.3 Hesperos Lung-on-a-chip Introduction
11.3.4 Hesperos Revenue in Lung-on-a-chip Business (2018-2023)
11.3.5 Hesperos Recent Development
11.4 CN Bio Innovations
11.4.1 CN Bio Innovations Company Detail
11.4.2 CN Bio Innovations Business Overview
11.4.3 CN Bio Innovations Lung-on-a-chip Introduction
11.4.4 CN Bio Innovations Revenue in Lung-on-a-chip Business (2018-2023)
11.4.5 CN Bio Innovations Recent Development
11.5 Draper Laboratory
11.5.1 Draper Laboratory Company Detail
11.5.2 Draper Laboratory Business Overview
11.5.3 Draper Laboratory Lung-on-a-chip Introduction
11.5.4 Draper Laboratory Revenue in Lung-on-a-chip Business (2018-2023)
11.5.5 Draper Laboratory Recent Development
11.6 Mimetas
11.6.1 Mimetas Company Detail
11.6.2 Mimetas Business Overview
11.6.3 Mimetas Lung-on-a-chip Introduction
11.6.4 Mimetas Revenue in Lung-on-a-chip Business (2018-2023)
11.6.5 Mimetas Recent Development
11.7 Nortis
11.7.1 Nortis Company Detail
11.7.2 Nortis Business Overview
11.7.3 Nortis Lung-on-a-chip Introduction
11.7.4 Nortis Revenue in Lung-on-a-chip Business (2018-2023)
11.7.5 Nortis Recent Development
11.8 Kirkstall
11.8.1 Kirkstall Company Detail
11.8.2 Kirkstall Business Overview
11.8.3 Kirkstall Lung-on-a-chip Introduction
11.8.4 Kirkstall Revenue in Lung-on-a-chip Business (2018-2023)
11.8.5 Kirkstall Recent Development
11.9 Cherry Biotech SAS
11.9.1 Cherry Biotech SAS Company Detail
11.9.2 Cherry Biotech SAS Business Overview
11.9.3 Cherry Biotech SAS Lung-on-a-chip Introduction
11.9.4 Cherry Biotech SAS Revenue in Lung-on-a-chip Business (2018-2023)
11.9.5 Cherry Biotech SAS Recent Development
11.10 Else Else Kooi Laboratory
11.10.1 Else Else Kooi Laboratory Company Detail
11.10.2 Else Else Kooi Laboratory Business Overview
11.10.3 Else Else Kooi Laboratory Lung-on-a-chip Introduction
11.10.4 Else Else Kooi Laboratory Revenue in Lung-on-a-chip Business (2018-2023)
11.10.5 Else Else Kooi Laboratory Recent Development
11.11 Micronit Microtechnologies B.V.
11.11.1 Micronit Microtechnologies B.V. Company Detail
11.11.2 Micronit Microtechnologies B.V. Business Overview
11.11.3 Micronit Microtechnologies B.V. Lung-on-a-chip Introduction
11.11.4 Micronit Microtechnologies B.V. Revenue in Lung-on-a-chip Business (2018-2023)
11.11.5 Micronit Microtechnologies B.V. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
*If Applicable.
Links
[1] https://www.marketresearchreports.com/countries/global[2] https://www.marketresearchreports.com/pharma-healthcare[3] https://www.marketresearchreports.com/healthcare[4] https://www.marketresearchreports.com/it-ehealth[5] https://www.marketresearchreports.com/medical-devices[6] https://www.marketresearchreports.com/pharma-healthcare-technology[7] https://www.marketresearchreports.com/research-development-pharma-healthcare[8] https://www.marketresearchreports.com/mrrpb5/organ-chip-ooc-market-size-competition-and-demand-analysis-report-insights